Cargando…

Gut Microbiota: A Novel Regulator of Cardiovascular Disease and Key Factor in the Therapeutic Effects of Flavonoids

Cardiovascular disease is the main cause of death worldwide, and traditional cardiovascular risk factors cannot fully explain the occurrence of the disease. In recent years, the relationship between gut microbiota and its metabolites and cardiovascular disease has been a hot study topic. The changes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Qinyu, Gao, Bing, Siqin, Bateer, He, Qian, Zhang, Ru, Meng, Xiangxi, Zhang, Naiheng, Zhang, Na, Li, Minhui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8241904/ https://www.ncbi.nlm.nih.gov/pubmed/34220497 http://dx.doi.org/10.3389/fphar.2021.651926

Ejemplares similares

Effects of Koumiss on Intestinal Immune Modulation in Immunosuppressed Rats
por: Li, Qinyu, et al.
Publicado: (2022)

Gut Microbiota-Dependent Marker TMAO in Promoting Cardiovascular Disease: Inflammation Mechanism, Clinical Prognostic, and Potential as a Therapeutic Target
por: Yang, Shengjie, et al.
Publicado: (2019)

Gut microbiota: A new therapeutic target for diabetic cardiomyopathy
por: Yuan, Suxin, et al.
Publicado: (2022)

Editorial: Gut Microbiota and Inflammation: Relevance in Cancer and Cardiovascular Disease
por: Parolini, Cinzia, et al.
Publicado: (2020)

Gut Microbiota: Novel Therapeutic Target of Ginsenosides for the Treatment of Obesity and Its Complications
por: Zhuang, Tongxi, et al.
Publicado: (2021)

Naoxintong Capsule Inhibits the Development of Cardiovascular Pathological Changes in Bama Minipig Through Improving Gut Microbiota
por: Zhang, Wei-jian, et al.
Publicado: (2019)

Integrated Phytochemical Analysis Based on UPLC–MS/MS and Network Pharmacology Approaches to Explore the Effect of Odontites vulgaris Moench on Rheumatoid Arthritis
por: Ji, Mingyue, et al.
Publicado: (2021)

The Role of Gut Microbiota and Microbiota-Related Serum Metabolites in the Progression of Diabetic Kidney Disease
por: Zhang, Qing, et al.
Publicado: (2021)

The Role of Gut Microbiota—Gut—Brain Axis in Perioperative Neurocognitive Dysfunction
por: Lu, Jian, et al.
Publicado: (2022)

The regulatory effects of second-generation antipsychotics on lipid metabolism: Potential mechanisms mediated by the gut microbiota and therapeutic implications
por: Chen, Hui, et al.
Publicado: (2023)

Canagliflozin Prevents Lipid Accumulation, Mitochondrial Dysfunction, and Gut Microbiota Dysbiosis in Mice With Diabetic Cardiovascular Disease
por: Wang, Xueliang, et al.
Publicado: (2022)

Characteristics of Serum Metabolites and Gut Microbiota in Diabetic Kidney Disease
por: Zhang, Bo, et al.
Publicado: (2022)

Changes in the Gut Microbiota May Affect the Clinical Efficacy of Oral Anticoagulants
por: Chen, Wenjun, et al.
Publicado: (2022)

The Role of Gut Microbiota in Atherosclerosis and Hypertension
por: Ma, Junli, et al.
Publicado: (2018)

Editorial: Dietary polyphenols, gut microbiota, and human health
por: Xu, Lei, et al.
Publicado: (2023)

Gut Microbiota-Based Pharmacokinetics and the Antidepressant Mechanism of Paeoniflorin
por: Yu, Jin-Bo, et al.
Publicado: (2019)

Resveratrol Modulates the Gut Microbiota and Inflammation to Protect Against Diabetic Nephropathy in Mice
por: Cai, Ting-Ting, et al.
Publicado: (2020)

Astragalin: a food-origin flavonoid with therapeutic effect for multiple diseases
por: Chen, Junren, et al.
Publicado: (2023)

Chlorogenic Acid Improves NAFLD by Regulating gut Microbiota and GLP-1
por: Shi, Ameng, et al.
Publicado: (2021)

Sini Decoction Ameliorates Colorectal Cancer and Modulates the Composition of Gut Microbiota in Mice
por: Wang, Yishan, et al.
Publicado: (2021)

Natural flavonoids: Potential therapeutic strategies for non-alcoholic fatty liver disease
por: Tan, Panli, et al.
Publicado: (2022)

Emodin in cardiovascular disease: The role and therapeutic potential
por: Guo, Yuanyuan, et al.
Publicado: (2022)

Understanding the Gut-Kidney Axis in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: An Analysis of Gut Microbiota Composition
por: Yu, Meilian, et al.
Publicado: (2022)

Combining fecal microbiome and metabolomics to reveal the disturbance of gut microbiota in liver injury and the therapeutic mechanism of shaoyao gancao decoction
por: Li, Jingwei, et al.
Publicado: (2022)

Update on gut microbiota in cardiovascular diseases
por: Qian, Buyun, et al.
Publicado: (2022)

Ferulic Acid Ameliorates Atherosclerotic Injury by Modulating Gut Microbiota and Lipid Metabolism
por: Gu, Yuyan, et al.
Publicado: (2021)

Herbal Medicine, Gut Microbiota, and COVID-19
por: Chen, Ziqi, et al.
Publicado: (2021)

Study on mechanism of action of total flavonoids from Cortex Juglandis Mandshuricae against alcoholic liver disease based on “gut-liver axis”
por: Liu, Huiru, et al.
Publicado: (2023)

Endoplasmic reticulum as a target in cardiovascular diseases: Is there a role for flavonoids?
por: Keylani, Kimia, et al.
Publicado: (2023)

The gut-lung axis: Gut microbiota changes associated with pulmonary fibrosis in mouse models induced by bleomycin
por: Quan, Yunyun, et al.
Publicado: (2022)

NSAID–Gut Microbiota Interactions
por: Maseda, Damian, et al.
Publicado: (2020)

Gut microbiota-derived metabolites in inflammatory diseases based on targeted metabolomics
por: Xu, Hui, et al.
Publicado: (2022)

Role of Butyrate, a Gut Microbiota Derived Metabolite, in Cardiovascular Diseases: A comprehensive narrative review
por: Amiri, Parichehr, et al.
Publicado: (2022)

Antidepressant Effects of Rosemary Extracts Associate With Anti-inflammatory Effect and Rebalance of Gut Microbiota
por: Guo, Ying, et al.
Publicado: (2018)

The role of gut microbiota and drug interactions in the development of colorectal cancer
por: Wu, Jinna, et al.
Publicado: (2023)

Effects of Xylooligosaccharides on Lipid Metabolism, Inflammation, and Gut Microbiota in C57BL/6J Mice Fed a High-Fat Diet
por: Li, Fang, et al.
Publicado: (2021)

Distinct common signatures of gut microbiota associated with damp-heat syndrome in patients with different chronic liver diseases
por: Pan, Yuqing, et al.
Publicado: (2022)

Potential benefits of metformin and pioglitazone combination therapy via gut microbiota and metabolites in high-fat diet-fed mice
por: Wang, Dongmei, et al.
Publicado: (2022)

Advances in natural compound-based nanomedicine and the interaction with gut microbiota in ulcerative colitis therapy
por: Zhang, Jinlan, et al.
Publicado: (2023)

New insights into natural products that target the gut microbiota: Effects on the prevention and treatment of colorectal cancer
por: Lu, Lu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_aq3jg8isol01eulumuqtf3jtea